This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

No content found

Data pager
Data pager
12
 Item 1 to 99 of 153
of 2 
Show all 153
Data pager
Data pager
12
 Item 1 to 99 of 153
of 2 
Show all 153
Thursday, March 27 | 3:00PM - 7:30PM
Registration
Room: Van Horne Ballroom Foyer


Thursday, March 27 | 6:30PM - 7:30PM
Refreshments
Room: Van Horne Ballroom Foyer


Thursday, March 27 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Van Horne Ballroom AB

Speaker 1 of 4
* Steven Wolinsky, Northwestern University, USA

Thursday, March 27 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Van Horne Ballroom AB

Speaker 2 of 4
Henry A. Erlich, Roche Molecular Systems, USA
HLA Allelic and Haplotypic Diversity and Host Immunity


Thursday, March 27 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Van Horne Ballroom AB

Speaker 3 of 4
Dan H. Barouch, Beth Israel Deaconess Medical Center, USA

Thursday, March 27 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Van Horne Ballroom AB

Speaker 4 of 4
Lawrence Corey, Fred Hutchinson Cancer Research Center, USA
HIV Vaccines: The Way Forward

Friday, March 28 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Friday, March 28 | 8:00AM - 11:00AM
Biology of Transmission (Joint)
Room: Van Horne Ballroom AB

Speaker 1 of 6
* Steven Wolinsky, Northwestern University, USA

Friday, March 28 | 8:00AM - 11:00AM
Biology of Transmission (Joint)
Room: Van Horne Ballroom AB

Speaker 2 of 6
Ashley T. Haase, University of Minnesota, USA
Sexual Mucosal Transmission

Friday, March 28 | 8:00AM - 11:00AM
Biology of Transmission (Joint)
Room: Van Horne Ballroom AB

Speaker 3 of 6
Daniel C. Douek, NIAID, National Institutes of Health, USA
Immune Events in the HIV-Infected Gut

Friday, March 28 | 8:00AM - 11:00AM
Biology of Transmission (Joint)
Room: Van Horne Ballroom AB

Speaker 4 of 6
Thomas J. Hope, Northwestern University, USA
Analysis of the Early Interactions of HIV with Human Cervical Explants and the Rhesus Macaque Female Genital Tract: The First 4 Hours of Virus Exposure

Friday, March 28 | 8:00AM - 11:00AM
Biology of Transmission (Joint)
Room: Van Horne Ballroom AB

Speaker 5 of 6
James Arthos, NIAID, National Institutes of Health, USA
Short Talk: HIV-1 Envelope Binds to and Signals through alpha4beta7 Integrin, the Gut Mucosal Homing Receptor for Peripheral T Cells

Friday, March 28 | 8:00AM - 11:00AM
Biology of Transmission (Joint)
Room: Van Horne Ballroom AB

Speaker 6 of 6
Frank Wegmann, Janssen, Netherlands
Short Talk: Combining HIV Antigens and Polyanionic Microbicides to Induce High Levels of Mucosal Env-Specific Antibodies

Friday, March 28 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Friday, March 28 | 11:00AM - 1:00PM
Poster Setup
Room: New Brunswick, Alberta, Cascade


Friday, March 28 | 12:00PM - 1:30PM
Hands-on Computer Session on Los Alamos Sequence Database
This session is from HIV Pathogenesis
Room: Beatty/Coleman
Maximum attendance: 60. Interested participants may sign up at the meeting on a first-come, first-serve basis.
Speaker 1 of 2
Thomas K. Leitner, Los Alamos National Laboratory, USA


Friday, March 28 | 12:00PM - 1:30PM
Hands-on Computer Session on Los Alamos Sequence Database
This session is from HIV Pathogenesis
Room: Beatty/Coleman
Maximum attendance: 60. Interested participants may sign up at the meeting on a first-come, first-serve basis.
Speaker 2 of 2
Bette Tina Marie Korber, Los Alamos National Laboratory, USA


Friday, March 28 | 1:00PM - 10:00PM
Poster Viewing
Room: New Brunswick, Alberta, Cascade


Friday, March 28 | 2:30PM - 4:30PM
Workshop 1 : Novel Vaccines and Adjuvants
Room: Van Horne Ballroom C

Speaker 1 of 9
* Rama Rao Amara, Emory University, USA

Friday, March 28 | 2:30PM - 4:30PM
Workshop 1 : Novel Vaccines and Adjuvants
Room: Van Horne Ballroom C

Speaker 2 of 9
* Robert A. Seder, NIAID, National Institutes of Health, USA

Friday, March 28 | 2:30PM - 4:30PM
Workshop 1 : Novel Vaccines and Adjuvants
Room: Van Horne Ballroom C

Speaker 3 of 9
Tomas Hanke, University of Oxford, UK
Development of a Universal T Cell Vaccine

Friday, March 28 | 2:30PM - 4:30PM
Workshop 1 : Novel Vaccines and Adjuvants
Room: Van Horne Ballroom C

Speaker 4 of 9
Antu K. Dey, International AIDS Vaccine Initiative, USA
N-Terminal Substitutions in HIV-1 gp41 Reduce the Expression of non-Trimeric Envelope Glycoproteins on the Virus

Friday, March 28 | 2:30PM - 4:30PM
Workshop 1 : Novel Vaccines and Adjuvants
Room: Van Horne Ballroom C

Speaker 5 of 9
Gerald Kimani Chege, South African Medical Research Council, South Africa
A Pantothenate Auxotrophic Strain of BCG Expressing HIV-1 Gag Induces Cellular Responses in Baboons, which are Efficiently Boosted by HIV-1 Pr55gag VLPs

Friday, March 28 | 2:30PM - 4:30PM
Workshop 1 : Novel Vaccines and Adjuvants
Room: Van Horne Ballroom C

Speaker 6 of 9
Mario Roederer, NIAID, National Institutes of Health, USA
Fine Aerosol Adenovirus Vaccination against SIV and Tuberculosis in Rhesus Macaque

Friday, March 28 | 2:30PM - 4:30PM
Workshop 1 : Novel Vaccines and Adjuvants
Room: Van Horne Ballroom C

Speaker 7 of 9
David B. Weiner, Wistar Institute, USA
Induction of Potent T Cell Immunity in Macaques by EP DNA + Molecular Adjuvants, Comparison of -Specific Responses Induced by Co-Vaccination of SIV DNA + Plasmid IL-12, IL-15 or RANTES in Rhesus Macaques

Friday, March 28 | 2:30PM - 4:30PM
Workshop 1 : Novel Vaccines and Adjuvants
Room: Van Horne Ballroom C

Speaker 8 of 9
† Sean X. Du, Maxygen, USA
Directed Molecular Evolution Created Genetic and Antigenic Diversity and Improved Overall Immunogenicity of HIV-1 gp120 Immunogen

Friday, March 28 | 2:30PM - 4:30PM
Workshop 1 : Novel Vaccines and Adjuvants
Room: Van Horne Ballroom C

Speaker 9 of 9
Mattias Forsell, Umeå University, Sweden
Elicitation of Co-Receptor Site Directed Antibodies against HIV-1 is caused by Primary Receptor Binding to the Viral Envelope Glycoproteins

Friday, March 28 | 2:30PM - 4:30PM
Workshop 1: Pathogenic and Non-Pathogenic Pathways
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 8
* Cristian Apetrei, University of Pittsburgh, USA
Experimentally-Induced Immune Activation in Natural Hosts of SIVs Results in Significant Increases in Viral Replication


Friday, March 28 | 2:30PM - 4:30PM
Workshop 1: Pathogenic and Non-Pathogenic Pathways
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 8
* Genoveffa Franchini, NCI, National Institutes of Health, USA
Preferential Loss of Th17 T Cells at Mucosal Sites and Immune Activation Predicts AIDS Progression


Friday, March 28 | 2:30PM - 4:30PM
Workshop 1: Pathogenic and Non-Pathogenic Pathways
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 8
Mirko Paiardini, Emory University, YNPRC, USA
Th17 Cells in the Gut of Naturally SIV-Infected Sooty Mangabeys


Friday, March 28 | 2:30PM - 4:30PM
Workshop 1: Pathogenic and Non-Pathogenic Pathways
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 8
Satya Dandekar, University of California, Davis, USA
Early Onset of Enteropathic Changes in SIV Infection Lead to Impaired IL-17 Orchestrated Gut Mucosal Immune Response Against Salmonella and cause its Systemic Dissemination from the Gut


Friday, March 28 | 2:30PM - 4:30PM
Workshop 1: Pathogenic and Non-Pathogenic Pathways
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 8
Joern E. Schmitz, Beth Israel Deaconess Medical Center, USA
Adaptive Immune Responses Appear to Contribute Little to Viral Containment of SIVagm infection in African Green Monkeys


Friday, March 28 | 2:30PM - 4:30PM
Workshop 1: Pathogenic and Non-Pathogenic Pathways
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 6 of 8
Thaidra A. Gaufin, Tulane National Primate Research Center, USA
Humoral Immune Responses have Little Impact on Controlling Viremia during SIVagm Infection of African Green Monkeys (AGMs)


Friday, March 28 | 2:30PM - 4:30PM
Workshop 1: Pathogenic and Non-Pathogenic Pathways
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 7 of 8
Andre Durudas, Seattle Biomedical Research Institute, USA
Tissue Specific Inflammatory Responses are Associated with Disease Outcome Following Oral SIV Transmission


Friday, March 28 | 2:30PM - 4:30PM
Workshop 1: Pathogenic and Non-Pathogenic Pathways
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 8 of 8
S. Rochelle Mikkelsen, North Carolina State University, USA
Transient Depletion of CD4+CD25+ Regulatory T Cells in Cats Chronically Infected with Feline Immunodeficiency Virus Improves Anti-Viral and Novel Immune Responses


Friday, March 28 | 4:30PM - 5:00PM
Coffee Available
Room: Van Horne Ballroom Foyer


Friday, March 28 | 5:00PM - 7:30PM
Progress in Clinical Trials of HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 7
* Peggy Johnston, NIAID, National Institutes of Health, USA

Friday, March 28 | 5:00PM - 7:30PM
Progress in Clinical Trials of HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 7
Susan P. Buchbinder, San Francisco Department of Public Health, USA
Primary Efficacy Results from the STEP Study (Merck V520 Protocol 023/HVTN 502)—a Phase II Test-of-Concept Trial of the MRKAd5 HIV-1 gag/pol/nef Trivalent Vaccine

Friday, March 28 | 5:00PM - 7:30PM
Progress in Clinical Trials of HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 7
M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
T Lymphocyte Responses Elicited by Current Vaccines

Friday, March 28 | 5:00PM - 7:30PM
Progress in Clinical Trials of HIV Vaccines
Room: Van Horne Ballroom C

Speaker 4 of 7
Gary J. Nabel, Sanofi, USA
Criteria for Advancement of Novel Vaccine Candidates

Friday, March 28 | 5:00PM - 7:30PM
Progress in Clinical Trials of HIV Vaccines
Room: Van Horne Ballroom C

Speaker 5 of 7
William Snow, AIDS Vaccine Advocacy Coalition, USA
Short Talk: STEP-ing Forward: Community Perspectives on Communication and Decision-Making in the MRK-Ad5 Trials

Friday, March 28 | 5:00PM - 7:30PM
Progress in Clinical Trials of HIV Vaccines
Room: Van Horne Ballroom C

Speaker 6 of 7
Harriet L. Robinson, GeoVax Inc., USA
Short Talk: GeoVax Clade B DNA/MVA HIV/AIDS Vaccine is well Tolerated and Immunogenic when Administered to Healthy Seronegative Adults (HVTN 065 part A)

Friday, March 28 | 5:00PM - 7:30PM
Progress in Clinical Trials of HIV Vaccines
Room: Van Horne Ballroom C

Speaker 7 of 7
Laura Papagno, INSERM U543 Laboratoire d'Immunologie Cellulaire, France
Short Talk: Comprehensive Analysis of Virus-Specific CD8+ and CD4+ T Cells Provides Clues for the Failure of Therapeutic Immunization with ALVAC-HIV (vCP1452) Vaccine

Friday, March 28 | 5:00PM - 7:15PM
Host and Viral Genetics
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 6
* Bette Tina Marie Korber, Los Alamos National Laboratory, USA


Friday, March 28 | 5:00PM - 7:15PM
Host and Viral Genetics
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 6
Sunil K. Ahuja, University of Texas Health Science Center, USA
Host Factors and Pathogenesis


Friday, March 28 | 5:00PM - 7:15PM
Host and Viral Genetics
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 6
Mary Carrington, NCI, National Institutes of Health, USA
The Influence of HLA Class I and KIR on HIV-1 Disease


Friday, March 28 | 5:00PM - 7:15PM
Host and Viral Genetics
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 6
Beatrice H. Hahn, University of Pennsylvania, USA
HIV-1 Transmission and Early Viral Evolution


Friday, March 28 | 5:00PM - 7:15PM
Host and Viral Genetics
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 6
Christine M. Rousseau, University of Washington, USA
Short Talk: HLA-Driven Evolution of HIV-1 Subtype C: Immune Escape and Viral Fitness Costs


Friday, March 28 | 5:00PM - 7:15PM
Host and Viral Genetics
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 6 of 6
Athe M.N. Tsibris, Massachusetts General Hospital, USA
Short Talk: V3 Loop Sequence Dynamics in Subjects Failing CCR5 Antagonist Therapy


Friday, March 28 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: New Brunswick, Alberta, Cascade


Friday, March 28 | 7:30PM - 10:00PM
Poster Session 1
Room: New Brunswick, Alberta, Cascade


Saturday, March 29 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Saturday, March 29 | 8:00AM - 11:00AM
Intracellular Events
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 5
* Robert W. Doms, University of Pennsylvania School of Medicine, USA
HIV Entry and its Inhibition


Saturday, March 29 | 8:00AM - 11:00AM
Intracellular Events
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 5
Katherine A. Jones, The Salk Institute, USA
Transcription Elongation by HIV-1 Tat Links to Histone Methylation


Saturday, March 29 | 8:00AM - 11:00AM
Intracellular Events
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 5
Frederic D. Bushman, University of Pennsylvania, USA
Retroviral DNA Integration: Mechanism and Consequences


Saturday, March 29 | 8:00AM - 11:00AM
Intracellular Events
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 5
Daria J. Hazuda, Merck Research Laboratories, USA
Inhibitors of HIV-1 Integrase: Lessons from the Analysis of Resistance Derived in vivo and in vitro


Saturday, March 29 | 8:00AM - 11:00AM
Intracellular Events
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 5
Eiji Morita, Hirosaki University, Japan
Short Talk: Identification of ESCRT-I Binding Factors Required for Efficient HIV-1 Release


Saturday, March 29 | 8:00AM - 8:20AM
Special Lecture
Room: Van Horne Ballroom C

Speaker 1 of 1
Alan Bernstein, Canadian Institute for Advanced Research, Canada
Special Lecture

Saturday, March 29 | 8:00AM - 11:00AM
Optimization of Vectors and T Lymphocyte Responses
Room: Van Horne Ballroom C

Speaker 1 of 6
* Nina D. Russell, Bill & Melinda Gates Foundation, USA

Saturday, March 29 | 8:00AM - 11:00AM
Optimization of Vectors and T Lymphocyte Responses
Room: Van Horne Ballroom C

Speaker 2 of 6
Giuseppe Pantaleo, Centre Hospitalier Universitaire Vaudois, Switzerland
Novel Poxvirus Vectors

Saturday, March 29 | 8:00AM - 11:00AM
Optimization of Vectors and T Lymphocyte Responses
Room: Van Horne Ballroom C

Speaker 3 of 6
Danilo R. Casimiro, Aeras, USA
What's Next After STEP? Implications on Vaccine Design

Saturday, March 29 | 8:00AM - 11:00AM
Optimization of Vectors and T Lymphocyte Responses
Room: Van Horne Ballroom C

Speaker 4 of 6
Dan H. Barouch, Beth Israel Deaconess Medical Center, USA
Novel Adenovirus Vector-Based Vaccines for HIV-1

Saturday, March 29 | 8:00AM - 11:00AM
Optimization of Vectors and T Lymphocyte Responses
Room: Van Horne Ballroom C

Speaker 5 of 6
Stephen C. De Rosa, University of Washington, Fred Hutchinson Cancer Research Center, USA
Short Talk: Kinetics of T Cell Responses to Vaccination for HIV with Heterologous DNA Prime-rAd5 Boost Contrasted with Homologous rAd5 Prime-Boost

Saturday, March 29 | 8:00AM - 11:00AM
Optimization of Vectors and T Lymphocyte Responses
Room: Van Horne Ballroom C

Speaker 6 of 6
Rama Rao Amara, Emory University, USA
Short Talk: Preexisting Immunity to Vaccinia Reduces the Frequency of SIV-Specific CCR-5+ve but not CCR-7+ve CD4 T Cells Elicited by a DNA/MVA Vaccine and Enhances the Control of SIV251 Challenge

Saturday, March 29 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Saturday, March 29 | 11:00AM - 1:00PM
Poster Setup
Room: New Brunswick, Alberta, Cascade


Saturday, March 29 | 12:00PM - 1:30PM
Hands-on Computer Session on Los Alamos Sequence/Immunology
Databases
This session is from HIV Pathogenesis
Room: Beatty/Coleman
Maximum attendance: 60. Interested participants may sign up at the meeting on a first-come, first-serve basis.
Speaker 1 of 2
Thomas K. Leitner, Los Alamos National Laboratory, USA


Saturday, March 29 | 12:00PM - 1:30PM
Hands-on Computer Session on Los Alamos Sequence/Immunology
Databases
This session is from HIV Pathogenesis
Room: Beatty/Coleman
Maximum attendance: 60. Interested participants may sign up at the meeting on a first-come, first-serve basis.
Speaker 2 of 2
Bette Tina Marie Korber, Los Alamos National Laboratory, USA


Saturday, March 29 | 1:00PM - 10:00PM
Poster Viewing
Room: New Brunswick, Alberta, Cascade


Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Mucosal/Innate Immunity
Room: Van Horne Ballroom C

Speaker 1 of 9
* M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA

Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Mucosal/Innate Immunity
Room: Van Horne Ballroom C

Speaker 2 of 9
* Karin Loré, Karolinska Institutet, Sweden

Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Mucosal/Innate Immunity
Room: Van Horne Ballroom C

Speaker 3 of 9
Kimberly Ann Schoenly, University of Pennsylvania, USA
Systemic and Mucosal Immune Responses Elicited by Electroporation Delivered Mucosal Targeting Chemokine DNA Vaccines in Mice and Macaques

Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Mucosal/Innate Immunity
Room: Van Horne Ballroom C

Speaker 4 of 9
David R. Kaufman, Merck Research Laboratories, USA
Systemic Vaccination with Hetrologous Recombinant Adenovirus Prime-Boost Regimens Elicits Potent and Durable Mucosal Immunity

Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Mucosal/Innate Immunity
Room: Van Horne Ballroom C

Speaker 5 of 9
Cornelia Gujer, Karolinska Institutet, Sweden
Dendritic Cell Mediated Support of Human B Cell Responses Via Toll-Like Receptor Ligands

Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Mucosal/Innate Immunity
Room: Van Horne Ballroom C

Speaker 6 of 9
Kathlyn Santos, NIAID, National Institutes of Health, USA
Immunomodulation of Human Dendritic Cells by MVA and Ad5 Vaccine Vectors

Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Mucosal/Innate Immunity
Room: Van Horne Ballroom C

Speaker 7 of 9
Elizabeth Rhee, Beth Israel Deaconess Medical Center, USA
Rare Serotype Recombinant Adenovirus Vaccine Vectors Elicit Expression of Type I Interferon

Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Mucosal/Innate Immunity
Room: Van Horne Ballroom C

Speaker 8 of 9
Salix Boulet, Université de Montréal, Canada
Increased Expression of KIR3DL1 Subtypes and HLA-B57 in HIV Exposed Uninfected (EU) versus HIV Susceptible Individuals

Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Mucosal/Innate Immunity
Room: Van Horne Ballroom C

Speaker 9 of 9
Patrice Debré, Hopital Pitie Salpetriere, France
A New Concept for HIV Vaccine Preventing CD4 T Cell Depletion

Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Aspects of Progression
This session is from HIV Pathogenesis

Speaker 1 of 7
* Bette Tina Marie Korber, Los Alamos National Laboratory, USA


Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Aspects of Progression
This session is from HIV Pathogenesis

Speaker 2 of 7
Jason Ho, NIAID, National Institutes of Health, USA
HIV-Specific B Cells Are Enriched in a Dysfunctional Tissue-like Memory B-Cell Compartment in HIV-Infected Viremic Individuals


Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Aspects of Progression
This session is from HIV Pathogenesis

Speaker 3 of 7
David M. Kuhrt, Maine Medical Center Research Institute, USA
Phenotypic Perturbation of the B Cell Compartment During Acute Simian Immunodeficiency Virus Infection


Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Aspects of Progression
This session is from HIV Pathogenesis

Speaker 4 of 7
* Jason M. Brenchley, NIAID, National Institutes of Health, USA
Th17 Cells are Preferentially Depleted from GI Tract, but not BAL or Blood, of HIV-Infected Individuals


Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Aspects of Progression
This session is from HIV Pathogenesis

Speaker 5 of 7
Pratip K. Chattopadhyay, National Institutes of Health, USA
Does T-Cell Function during Acute/Early HIV Predict Outcome?


Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Aspects of Progression
This session is from HIV Pathogenesis

Speaker 6 of 7
Peter W. Hunt, University of California, San Francisco, USA
Inflammatory Consequences of Viral Control in HIV-infected Patients with Undetectable Plasma HIV RNA Levels in the Absence of Therapy


Saturday, March 29 | 2:30PM - 4:30PM
Workshop 2: Aspects of Progression
This session is from HIV Pathogenesis

Speaker 7 of 7
Paul de Bakker, Vertex Pharmaceuticals, USA
A Genome-Wide Association Study in HIV Elite Controllers to Identify Host Genetic Factors that Influence Viral Control in the Absence of Anti-Retroviral Therapy


Saturday, March 29 | 4:30PM - 5:00PM
Coffee Available
Room: Van Horne Ballroom Foyer


Saturday, March 29 | 5:00PM - 7:15PM
Prospects for Generating Broad Neutralizing Antibody Respons
es

Room: Van Horne Ballroom C

Speaker 1 of 6
* John R. Mascola, NIAID, National Institutes of Health, USA

Saturday, March 29 | 5:00PM - 7:15PM
Prospects for Generating Broad Neutralizing Antibody Respons
es

Room: Van Horne Ballroom C

Speaker 2 of 6
Peter D. Kwong, NIAID, National Institutes of Health, USA
CD4-Binding-Site Antibodies: Prospects, Complications and Crystallographic Analyses

Saturday, March 29 | 5:00PM - 7:15PM
Prospects for Generating Broad Neutralizing Antibody Respons
es

Room: Van Horne Ballroom C

Speaker 3 of 6
Munir Alam, Duke Human Vaccine Institute, USA
The Role of Hydrophobic CDRH3 Loops of the Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 in Binding gp41, Lipids and in HIV-1 Neutralization

Saturday, March 29 | 5:00PM - 7:15PM
Prospects for Generating Broad Neutralizing Antibody Respons
es

Room: Van Horne Ballroom C

Speaker 4 of 6
Quentin J. Sattentau, Sir William Dunn School of Pathology, UK
Novel Formulation, Adjuvantation and Delivery Strategies for Inducing Env-Specific Antibodies

Saturday, March 29 | 5:00PM - 7:15PM
Prospects for Generating Broad Neutralizing Antibody Respons
es

Room: Van Horne Ballroom C

Speaker 5 of 6
James E. Robinson, Tulane University Health Sciences Center, USA
Short Talk: SHIV-Infected Rhesus Macaques Develop Antibodies Recognizing Quaternary Epitope(s) Exposed on Autologous Virus Particles

Saturday, March 29 | 5:00PM - 7:15PM
Prospects for Generating Broad Neutralizing Antibody Respons
es

Room: Van Horne Ballroom C

Speaker 6 of 6
Nicole A. Doria-Rose, NIAID, National Institutes of Health, USA
Short Talk: Frequency and Phenotype of HIV gp120-Specific B Cells from Patients with Broadly Cross-Neutralizing Antibodies

Saturday, March 29 | 5:00PM - 7:15PM
Restriction Factors
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 5
Felipe DiazGriffero, Einstein, USA
Blocking Early Events in HIV-1 Infection


Saturday, March 29 | 5:00PM - 7:15PM
Restriction Factors
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 5
Ruzena Stranska, University of Massachusetts Medical School, USA
Short Talk: Heterokaryon Analysis Suggests the Existence of a Dominant Restriction to SIV Infection in Macrophages


Saturday, March 29 | 5:00PM - 7:15PM
Restriction Factors
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 5
* Michael H. Malim, King's College London, UK
APOBEC Proteins and Intrinsic Resistance to HIV Infection


Saturday, March 29 | 5:00PM - 7:15PM
Restriction Factors
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 5
Stuart J. Neil, King's College London, UK
Short Talk: Tetherin, A Novel Antiviral Inhibitpr of Retrovirus Release that is Targeted by the HIV-1 VPU Protein


Saturday, March 29 | 5:00PM - 7:15PM
Restriction Factors
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 5
Harmit S. Malik, Fred Hutchinson Cancer Research Center, USA
Viral Restriction: Evolutionary Signatures of the Arms-Race between Host and Virus


Saturday, March 29 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: New Brunswick, Alberta, Cascade


Saturday, March 29 | 7:30PM - 10:00PM
Poster Session 2
Room: New Brunswick, Alberta, Cascade


No content found

No content found

No content found